Plaque composition and histo-molecular mapping - a collaboration between CINQ, Department of Surgery, Biomedical and Molecular Sciences, and QCPU.
The VANGUARD Study uses ultrasound because it is an inexpensive, radiation-free, non-invasive, portable method that could be ideal for imaging the presence of vulnerable plaque before a heart attack or stroke may occur. To create this new detection tool, our team will be taking 3D ultrasound images from patients undergoing removal of their vessels by our Vascular Surgery department, and analysing this diseased tissue using highly advanced, cutting-edge ultrasound techniques at CINQ and histo-molecular techniques at the Queen’s Cardiopulmonary Unit.
Team on project: Dr. Amer Johri, Dr. Charles Hindmarch, Dr. Douglas James Cook, Dr. Stephen Pang, Dr. David Zelt, Dr. Patricia De Lima, Dr. Marie-France Hétu, Julia Herr, Christie Boswell-Patterson, Orli Chapman, Kathleen Harrison, and Dathan Liblik.
Funded by: Queen's University 2019 Translational Medicine Project Operating Grant